Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Acceleron Pharma (XLRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2011
Assets
Current Assets
Cash & Cash Equivalents	27,783	176,460	113,163	39,611	65,037
Marketable Securities	77,064	0	N/A	N/A	N/A
Receivables	3,628	3,367	3,616	2,776	1,660
TOTAL	$110,933	$182,307	$119,022	$43,861	$67,741

Non-Current Assets
PPE Net	3,106	3,087	3,705	4,059	4,911
Investments And Advances	31,134	0	0	0	0
Other Non-Current Assets	1,164	902	1,005	1,292	1,137
TOTAL	$35,404	$3,989	$4,710	$5,351	$6,048

Total Assets	$146,337	$186,296	$123,732	$49,212	$73,789

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	875	724	885	642	1,914
Accrued Expenses	12,400	6,848	6,927	6,153	4,513
TOTAL	$14,491	$9,253	$27,210	$38,802	$23,853

Non-Current Liabilities
Long Term Debt	N/A	N/A	N/A	16,525	N/A
Deferred Revenues	1,216	1,681	2,530	28,339	11,429
Other Non-Current Liabilities	17,187	14,124	30,753	275,261	245,942
TOTAL	$22,583	$20,758	$38,710	$301,383	$282,627

Total Liabilities	$37,074	$30,011	$65,920	$340,185	$306,480

Shareholders' Equity
Shares Outstanding, K	37,096	32,644	31,160	N/A	N/A
Common Shares	34	33	29	3	3
Retained earnings	-307,477	-243,583	-192,324	-290,976	-232,694
Other shareholders' equity	-220	0	0	0	0
TOTAL	$109,263	$156,285	$57,812	$-290,973	$-232,691

Total Liabilities And Equity	$146,337	$186,296	$123,732	$49,212	$73,789